NKTR · Nektar Therapeutics

$64.84 -3.42 (-5.01%) At close · Jul 20

Market Cap

$2.19B

33.79M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	CEO	$1,106,282	—	$942,081	$2,986,535	$1,106,282	$115,774	$6,256,954
Jonathan Zalevsky	Chief of Research and Development	$717,560	—	$271,750	$861,497	$452,000	$17,551	$2,320,358
Mark A. Wilson	Former Chief Legal Officer	$645,950	—	—	—	—	$21,951	$667,901

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	CEO	$1,084,590	—	—	$1,596,122	$976,131	$105,850	$3,762,693
Jonathan Zalevsky	Chief of Research and Development	$703,490	—	—	$460,420	$431,885	$15,825	$1,611,620
Mark A. Wilson	Former Chief Legal Officer	$540,000	—	—	$399,030	$336,600	$21,697	$1,297,327
Sandra Gardiner	CFO	—	—	—	—	—	$460,850	$460,850

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	CEO	$1,084,590	—	—	$927,160	$1,030,361	$93,465	$3,135,576
Jonathan Zalevsky	Chief of Research and Development	$703,490	—	—	$178,300	$400,989	$490,585	$1,773,364
Jillian Thomsen	CFO	$355,760	—	—	—	—	$883,999	$1,239,759
Mark A. Wilson	Former Chief Legal Officer	$540,000	—	—	$231,790	$307,800	$20,878	$1,100,468
Sandra Gardiner	CFO	—	—	—	—	—	$376,300	$376,300

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	CEO	$1,084,590	—	$4,032,255	$5,409,410	$650,754	$98,821	$11,275,830
Mark A. Wilson	Former Chief Legal Officer	$527,500	—	$1,629,478	$2,185,994	$194,400	$28,093	$4,565,465
Jillian Thomsen	CFO	$522,200	—	$1,629,478	$2,185,994	$198,000	$22,645	$4,558,317
Jonathan Zalevsky	Chief of Research and Development	$703,490	—	$1,325,673	$1,778,436	$253,256	$289,625	$4,350,480

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	CEO	$1,053,000	—	$5,691,794	$3,326,492	$1,000,350	$81,980	$11,153,616
Jonathan Zalevsky	Chief of Research and Development	$683,000	—	$2,391,094	$1,397,498	$471,270	$8,385	$4,951,247
Mark A. Wilson	Former Chief Legal Officer	$500,000	—	$1,707,078	$998,320	$287,500	$10,763	$3,503,661

Executive changes

Person	Role	Change	Effective	Filed
Linda Rubinstein	interim Chief Financial Officer	Appointed	2026-05-15	2026-05-08
Sandra Gardiner	interim Chief Financial Officer	Retired	2026-05-15	2026-05-08

Key facts CIK 906709 CUSIP 640268306 13F (30d) 13 filings 13 filers Visit website Investor relations